What Is Actually Going On in PCOS
PCOS is not a single disease but a syndrome — a cluster of symptoms with several possible underlying drivers. In roughly 70% of cases, insulin resistance is the central issue. When cells resist insulin's signals, the pancreas produces more of it. High circulating insulin stimulates the ovaries to produce more testosterone, which disrupts follicle development and prevents normal ovulation. The result: irregular periods, elevated androgens (causing acne and excess hair growth), and often difficulty conceiving.
Not all PCOS looks the same. The Rotterdam criteria (the standard diagnostic tool) recognizes four phenotypes ranging from "full" PCOS with all features to lean PCOS with normal body weight and insulin sensitivity. This matters for treatment — a lean woman with PCOS may need a different approach than someone with metabolic syndrome.
The Insulin-Hormone Connection
Insulin acts as a co-gonadotropin in the ovaries, amplifying LH (luteinizing hormone) signaling and directly stimulating androgen production. High insulin also suppresses sex hormone-binding globulin (SHBG), which normally binds testosterone and renders it inactive. Lower SHBG means more free testosterone circulates — which worsens androgenic symptoms like acne, hair thinning on the scalp, and excess body hair.
This is why interventions that improve insulin sensitivity — whether dietary, supplemental, or through exercise — often produce the most meaningful improvements in PCOS.
Dietary Strategies
A low-glycemic, anti-inflammatory eating pattern is the most consistently supported dietary approach for PCOS. This means:
- Prioritizing whole foods over processed carbohydrates: vegetables, legumes, whole grains, quality proteins, and healthy fats
- Avoiding refined sugars and high-GI foods that spike insulin rapidly
- Including anti-inflammatory fats like olive oil, avocado, and fatty fish
- Eating adequate protein at each meal to slow glucose absorption and support satiety
A 2018 randomized controlled trial found that women with PCOS who followed a pulse-based diet (lentils, beans, chickpeas) combined with aerobic exercise for 16 weeks saw significant improvements in LDL cholesterol, waist-to-hip ratio, and hormonal markers compared to controls [7].
Low-carbohydrate diets, including ketogenic approaches, have shown promise in small studies for rapidly reducing insulin and testosterone, though long-term adherence is a common challenge.
Myo-Inositol: The Most Studied Supplement
Myo-inositol is a naturally occurring sugar-like compound that acts as a secondary messenger for insulin signaling. Women with PCOS have been shown to have inositol deficiency in follicular fluid. Supplementing restores normal insulin receptor sensitivity and has direct effects on ovarian follicle development.
In multiple randomized trials and meta-analyses, myo-inositol (typically 2–4 g/day) has improved:
- Fasting insulin and HOMA-IR (insulin resistance index)
- Menstrual cycle regularity
- Ovulation rates
- Testosterone levels
- Egg quality in women undergoing IVF
The 40:1 ratio of myo-inositol to D-chiro-inositol reflects the physiological ratio in the body and may be more effective than either form alone [1][2].
See our inositol page for a detailed breakdown of forms and dosing.
Berberine: A Natural Insulin Sensitizer
Berberine, an alkaloid found in plants like barberries and goldenseal, activates AMPK — the same cellular energy-sensing enzyme activated by the diabetes drug metformin. In head-to-head clinical trials, berberine has performed comparably to metformin for improving insulin sensitivity, reducing androgens, and restoring ovulation in PCOS, with a favorable safety profile [3].
Typical doses used in trials: 500 mg three times daily with meals.
See our berberine page for more detail.
Omega-3 Fatty Acids
EPA and DHA from fish oil target the inflammatory component of PCOS and directly influence hormone synthesis. Clinical trials show omega-3 supplementation at 2–4 g/day reduces:
- Triglycerides (elevated in PCOS-related dyslipidemia)
- Free testosterone
- Waist circumference
- Markers of inflammation (CRP, IL-6) [4]
See our omega-3 page for sourcing guidance.
Vitamin D
Vitamin D deficiency is extremely common in PCOS, affecting up to 85% of women in some studies, and correlates with worse insulin resistance and hormonal disruption. Supplementation (1,000–5,000 IU/day depending on baseline levels) alongside omega-3 has shown synergistic effects on testosterone, insulin markers, and inflammatory gene expression [5].
Exercise
Aerobic exercise and resistance training both improve insulin sensitivity and reduce androgens in PCOS, though they work through different mechanisms. Aerobic exercise is particularly effective for metabolic improvements; resistance training builds muscle mass which acts as a glucose sink. Current evidence supports at least 150 minutes per week of moderate exercise, with strength training included at least twice weekly [6].
Evidence Review
Epidemiology and Diagnosis
PCOS affects approximately 6–13% of women of reproductive age globally, making it the most prevalent endocrine disorder in this population [6]. Diagnostic criteria remain somewhat contested — the Rotterdam criteria (2 of 3: irregular ovulation, hyperandrogenism, or polycystic ovarian morphology on ultrasound) are most widely used, but some researchers argue this over-diagnoses the condition by including women with polycystic ovarian morphology alone.
The 2023 International Evidence-based PCOS Guidelines represent the most current synthesis of evidence, incorporating input from 37 organizations and over 6,000 women with PCOS. Lifestyle intervention is recommended as the first-line treatment, with pharmacological options second-line [6].
Inositol: Meta-Analytic Evidence
A 2012 meta-analysis by Unfer et al. (PMID 29042448) analyzing randomized controlled trials found that myo-inositol supplementation produced statistically significant decreases in fasting insulin (weighted mean difference: −4.61 mIU/L) and HOMA-IR, alongside improvements in ovulation rates and reductions in luteinizing hormone (LH) levels. Studies varied from 8 to 24 weeks of supplementation.
A 2024 systematic review and meta-analysis (PMID 38163998), specifically commissioned to inform the 2023 International PCOS Guidelines, analyzed 26 RCTs involving over 1,000 participants. Inositol treatment induced greater decreases in BMI, free testosterone, total testosterone, fasting glucose, and AUC insulin compared to placebo. The analysis concluded inositol is a "safe and effective treatment" — though the authors noted high heterogeneity between trials and called for larger, more standardized studies. Crucially, neither form was associated with serious adverse effects across all included trials.
Berberine vs. Metformin
The 2022 prospective RCT by Genazzani et al. (PMID 35251851) directly compared berberine, myo-inositol, and metformin over 3 months in 99 PCOS women. All three reduced LH/FSH ratio, testosterone, and HOMA-IR, with no statistically significant differences between groups on most parameters. Berberine showed a slightly superior lipid profile effect. This study was not blinded (open-label), a notable limitation.
Earlier work (Tan et al., 2017, Fertility and Sterility) found berberine 500 mg TID produced outcomes equivalent to metformin 500 mg TID in restoring ovulation and improving metabolic parameters, but with fewer GI side effects in some participants.
Omega-3 Fatty Acids
A 2022 review by Salek et al. (PMID 35180821) synthesized 12 clinical trials and cohort studies on omega-3 supplementation in PCOS. Across trials, omega-3 (typically 2–4 g/day for 8–24 weeks) consistently reduced triglycerides and free testosterone, with most trials showing 15–25% reductions in triglycerides. Effects on total testosterone were more variable, suggesting omega-3 is most useful as an adjunct rather than primary hormonal therapy.
Vitamin D and Omega-3 Co-Supplementation
Razavi et al. (PMID 29859385) conducted an 8-week double-blind RCT with 60 PCOS women (aged 18–40) comparing placebo to vitamin D (50,000 IU biweekly) plus omega-3 (2 g/day). The co-supplementation group showed significant reductions in total testosterone (from 0.89 ± 0.19 to 0.73 ± 0.18 ng/dL), high-sensitivity CRP, and malondialdehyde (an oxidative stress marker), alongside improved mental health scores. The simultaneous effect on multiple pathways supports a combined supplementation strategy.
Dietary and Exercise Interventions
Kazemi et al. (PMID 30274344) randomized 61 PCOS women to either a pulse-based diet or the Therapeutic Lifestyle Changes (TLC) diet, both combined with aerobic exercise (5 days/week, 45 min/day) and monthly health counseling for 16 weeks. The pulse-based diet group showed greater reductions in LDL cholesterol and improved waist-to-hip ratio. Both groups showed significant improvements from baseline in testosterone, sex hormone-binding globulin, and HOMA-IR — underscoring that consistent exercise and a whole-food dietary pattern are central, regardless of the specific diet composition.
Strength and Limitations of the Evidence
The evidence base for PCOS lifestyle and supplemental management has grown substantially but retains significant limitations: many trials are small (under 60 participants), use inconsistent diagnostic criteria, vary in supplementation dose and duration, and rarely extend beyond 6 months. Industry funding is common in inositol and omega-3 trials. Nonetheless, the consistency of effects across independent research groups and the favorable safety profiles of myo-inositol, omega-3, and berberine support their use as evidence-based adjuncts to dietary and lifestyle change — and as alternatives for women who cannot tolerate or prefer to avoid metformin.
The 2023 International Evidence-based PCOS Guidelines [6] explicitly endorse lifestyle modification as first-line therapy and note that inositol has sufficient evidence to recommend as an option for insulin sensitization, while calling for more high-quality trials on herbal interventions.